Data as of Q4 2025 (Dec 31, 2025)

GREENHAVEN ASSOCIATES INC

โ€ขCIK: 846222โ€ขFiling: Q4 2025

Greenhaven Associates Inc., managed by the seasoned investor team known for a concentrated, value-oriented approach, currently holds $6.2 billion in assets, with a notable 20% allocation to GM. Recently, the fund has shifted focus by exiting Goldman Sachs, cutting positions in Textron and Truist Financial, and adding significant stakes in Vertex Pharmaceuticals and Bristol Myers Squibb, reflecting a strategic pivot towards healthcare and industrials.

Total AUM
$6.2B
QoQ Performance
-6.2%
Positions
30
Top 10 Concentration
86.7%
Latest Filing
Q4 2025

Top Holdings Allocation

GM
LEN
TOL
PHM
DHI
OSK
GM20.0%
LEN16.8%
TOL12.3%
PHM10.5%
DHI8.1%
OSK5.1%
AVTR3.8%
ARW3.4%

๐Ÿ“ˆ Biggest Buys

SLB
SLB LTD (SLB)
NEW
2.9% of portfolio
BAX
Baxter International Inc (BAX)
+70.0%
3.3% of portfolio
LEN
Lennar Corporation - A (LEN)
+4.6%
16.8% of portfolio
AVTR
Avantor Inc (AVTR)
+12.0%
3.8% of portfolio
VBIL
Vanguard 0-3M T-Bill ETF (VBIL)
+54.5%
0.9% of portfolio

๐Ÿ“‰ Biggest Sells

GM
General Motors Co (GM)
-34.2%
20.0% of portfolio
TEX
Terex Corp (TEX)
-98.7%
0.0% of portfolio
DHI
D R Horton, Inc. (DHI)
-4.2%
8.1% of portfolio
TRVC
Citigroup Inc (C)
-60.1%
0.1% of portfolio
PHM
PulteGroup Inc. (PHM)
-0.6%
10.5% of portfolio

Sector Breakdown

Other80.2%
Consumer16.8%
Energy2.9%
Financial0.0%
Materials0.0%
Industrial0.0%

๐Ÿšช Exited Positionssold since Q3 2025

GS
Goldman Sachs (GS)
SOLD
$796.4K

Changes from Q3 2025

NEW4 new positions
โ†‘7 increased
โ†“13 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023